Zoe Diaz-Boyer

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension.

Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension.

Journal: Biology of sex differences

Published: November 20, 2024

GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASH.

GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASH.

Journal: JHEP reports : innovation in hepatology

Published: June 28, 2024

Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension.

Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension.

Journal: Gastroenterology

Published: September 28, 2023

Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical.

Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical.

Journal: Nutrients

Published: July 29, 2020

Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.

Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.

Journal: Journal of hepatology

Published: May 04, 2020

Animal models for liver disease - A practical approach for translational research.

Animal models for liver disease - A practical approach for translational research.

Journal: Journal of hepatology

Published: March 02, 2020

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease.

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease.

Journal: Nutrients

Published: August 29, 2019

New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease.

New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease.

Journal: Cells

Published: July 22, 2019

Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine Mechanism.

Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine Mechanism.

Journal: Hepatology communications

Published: January 29, 2019

GNIP1 E3 ubiquitin ligase is a novel player in regulating glycogen metabolism in skeletal muscle.

GNIP1 E3 ubiquitin ligase is a novel player in regulating glycogen metabolism in skeletal muscle.

Journal: Metabolism: clinical and experimental

Published: December 04, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026